Immunological mechanism of drug-induced liver injury
Journal Title: Journal of Clinical Hepatology - Year 2024, Vol 40, Issue 12
Abstract
Drug-induced liver injury （DILI） has a complex mechanism involving various pathways with a synergistic effect on each other and a causal relationship with each other， among which immune response plays an important role in the pathogenesis of DILI. In the context of genetic background， drug active metabolites， drug-molecule complexes， and danger signal molecules may be used as the trigger factors for immune response in DILI， activating the mechanism of drug antigenic hypersensitivity， P-i hypothesis， and danger signal mechanism in innate immunity. The cascade reaction of innate immunity and adaptive immunity leads to the imbalance of the innate immune tolerance of the liver and thus causes immunoinflammatory injury of liver tissue. This article mainly elaborates on the immunological mechanism of DILI， in order to provide new ideas for the research and development of therapeutic targets for DILI and the methods for avoiding adverse drug reactions.
Authors and Affiliations
Yu WANG, Shuang LI, Chenghai LIU
Keywords
Related Articles
- EP ID EP753936
- DOI 10.12449/JCH241227
- Views 5
- Downloads 0
Current status and prospects of the application of Mendelian randomization in pancreatic cancer research
Pancreatic cancer often has an insidious onset and difficulties in treatment， with various limitations in early diagnosis and treatment. This article reviews the application of Mendelian randomization （MR） in explorin...
Clinical efficacy of liver venous deprivation versus portal vein embolization in treatment of liver cancer with insufficient residual liver volume： A Meta-analysis
[Objective] To systematically evaluate the efficacy and prognosis of liver venous deprivation （LVD） versus portal vein embolization （PVE） in the treatment of hepatic malignancies with insufficient residual liver volu...
Efficacy and safety of camrelizumab monoclonal antibody combined with molecular-targeted therapy in elderly patients with advanced hepatocellular carcinoma
[Objective] To investigate the efficacy and safety of camrelizumab monoclonal antibody combined with molecular-targeted therapy in elderly patients with unresectable or advanced hepatocellular carcinoma （HCC）. [Methods...
Efficacy of des-γ-carboxy-prothrombin in the diagnosis of hepatocellular carcinoma and its association with the clinical features of hepatocellular carcinoma
[Objective] To investigate the value of des-γ-carboxy-prothrombin （DCP） in hepatocellular carcinoma （HCC）. [Methods] A retrospective analysis was performed for the clinical data of 179 HCC patients who were admitted...
Risk prediction models for pancreatic fistula after pancreaticoduodenectomy： A systematic review and a Meta-analysis
[Objective] To systematically review the risk prediction models for postoperative pancreatic fistula （POPF） after pancreaticoduodenectomy （PD）， and to provide a reference for the clinical screening and application o...